- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Trastuzumab Combined With Pertuzumab and Chemotherapy
Total 71 results
-
Peking University Cancer Hospital & InstituteRecruitingHER2-positive Metastatic Breast Cancer | Previously Treated With Trastuzumab | Trastuzumab Combined With Pertuzumab and ChemotherapyChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
UNICANCERGlaxoSmithKlineCompletedMetastatic Breast Cancer | 70 Years Old Patients and Over | After One Line of Chemotherapy With TrastuzumabFrance
-
Jilin UniversityUnknownAntineoplastic Combined Chemotherapy ProtocolsChina
-
NEMA Research, Inc.CompletedPeripheral Neuropathy | Antineoplastic Combined Chemotherapy ProtocolsUnited States
-
Xinqiao Hospital of ChongqingChongqing Medical UniversityNot yet recruitingThalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
-
Second Affiliated Hospital, School of Medicine,...Active, not recruitingEfficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) HNSCCChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and TaxaneChina
-
Peking Union Medical College HospitalBeijing Chao Yang Hospital; Beijing Obstetrics and Gynecology Hospital; San MediTech(Huzhou)Co... and other collaboratorsUnknownSANZ®KINGWILL Combined With CGM Equipment in GDM Patients | GLUCERNA SR® Combined With CGM Equipment in GDM PatientsChina
-
RenJi HospitalNot yet recruitingThird-line Treatment | Dvanced Duodenal Adenocarcinoma | Furquinelone Combined With Sintilimab
-
Cingulate TherapeuticsRecruitingPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Centre d'Investigation Clinique et Technologique...CompletedSelf Rehabilitation Combined With BTI on Upper LimbFrance
-
Pharmacosmos A/SCompletedPatients With Chemotherapy Induced Anemia (CIA)United States
-
Yanbing LiNot yet recruitingEfficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients | Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect | 128 Patients Were Randomly Assigned 1:1 | Metformin and Insulin Glargine Combined... and other conditionsChina
-
Xiamen LP Pharmaceutical Co., LtdCompletedNausea With Vomiting Chemotherapy-InducedUnited States
-
Hubei Cancer HospitalRecruitingNausea With Vomiting Chemotherapy-InducedChina
-
Cingulate TherapeuticsRho, Inc.CompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder CombinedUnited States
-
Yifeng YuCompletedRecurrent Pterygium | Micro-Conjunctival Autografting Combined With Amniotic Membrane TransplantationChina
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedSevere Combined Immunodeficiency | Adenosine Deaminase Deficiency | Immune System Disorder | Autosomal Recessive Disorder | Purine-Nucleoside Phosphorylase Deficiency | Severe Combined Immunodeficiency With Absence of T and B Cells | X-Linked Severe Combined ImmunodeficiencyUnited States
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Akdeniz UniversityCompletedPediatric Cancer | Nausea With Vomiting Chemotherapy-InducedTurkey
-
Mersin UniversityNot yet recruitingPain | Mental Health Wellness 1 | Nausea With Vomiting Chemotherapy-Induced
-
Université du Québec a MontréalUniversité de Sherbrooke; Université de Montréal; Paris West University Nanterre...Completed
-
Children's Hospital Medical Center, CincinnatiNational Institute of Mental Health (NIMH)CompletedADHD - Combined Type | ADHD - Inattentive TypeUnited States
-
University of YalovaRecruitingWomen Receiving Chemotherapy | 18 Years of Age and Above | Women With High Stress Levels | Women With Poor Sleep QualityTurkey
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la LoireCompletedHematological Malignancies Treated With Intensive ChemotherapyFrance
-
Cairo UniversityRecruitingto Investigate Influence of a Combined Interferential Current Stimulation and Abdominal Draw -in Exercises in Patients With Chronic nEgypt
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
CHU de ReimsCompletedPatients With Non-small Cell Lung Cancer (NSCLC) and Pleural Mesothelioma and Treated With a Pemetrexed-based ChemotherapyFrance
-
Peking Union Medical College HospitalNot yet recruitingEfficacy and Safety of Surufatinib Combined With Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients
-
Insel Gruppe AG, University Hospital BernRecruitingAortic Valve Replacement in Patients With Moderate Aortic Stenosis Combined With Mitral RegurgitationSwitzerland
-
MonoSol RxCompletedNausea With Vomiting Chemotherapy-Induced | Nausea and Vomiting, PostoperativeIndia
-
University of IcelandCompletedAttention Deficit Hyperactivity Disorder CombinedIceland
-
Sichuan UniversityNot yet recruitingCarrelizumab Plus Lenvatinib Combined With TACE | Borderline Resectable Hepatocellular CarcinomaChina
-
Hartford HospitalNational Institutes of Health (NIH)CompletedAttention-Deficit/Hyperactivity Disorder (Combined-subtype)United States
-
Donald Gilbert, MD, MS, FAAN, FAAPHugo W. Moser Research Institute at Kennedy Krieger, Inc.RecruitingAttention Deficit Hyperactivity Disorder CombinedUnited States
-
Gangnam Severance HospitalUnknownCytoreductive Surgery With Hyperthermic Intraperitoneal ChemotherapyKorea, Republic of
-
Haukeland University HospitalRecruitingADHD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - ImpulsiveNorway
-
Sun Yat-sen UniversityNot yet recruitingImmune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular CarcinomaChina
-
Sync-Think, Inc.Sutter HealthUnknownADHD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - ImpulsiveUnited States
-
The First Affiliated Hospital of Anhui Medical...CompletedLong-term Heart-specific Mortality in the Presence of Competing Risks Among Patients With Gastric Adenocarcinoma Undergoing Resection and Chemotherapy
-
Centre Francois BaclesseTerminatedHead and Neck Cancer | Radiotherapy by Tomotherapy Exclusive | With or Without Concurrent ChemotherapyFrance
-
Tang-Du HospitalCompletedSintilimab and Anlotinib in Combination With ChemotherapyChina
-
Eisai Inc.CompletedPatients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LECUnited States
-
Centre Antoine LacassagneCompletedNon-metastatic Patients With Breast Cancer | Non-metastatic Patients With Colon Cancer | Non-metastatic Patients With Rectal Cancer | Patients Undergoing Adjuvant ChemotherapyFrance
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingTo Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
-
The First Affiliated Hospital with Nanjing Medical...UnknownSystematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast CancerChina
-
AccareCompletedBehavioral Symptoms | Problem Behavior | ADHD | Child Behavior Problem | ADHD Predominantly Inattentive Type | ADHD - Combined Type | Behavior Problem | Disruptive Behavior | Behavioral Problem | ADHD, Predominantly Hyperactive-Impulsive TypeNetherlands
-
Sheba Medical CenterCompletedADHD Predominantly Inattentive Type | Attention Deficit/Hyperactivity Disorder Combined Type | ADHD Predominantly Hyperactivity Type | ADHD-not Other SpecifiedIsrael
-
Lawson Health Research InstituteRecruitingCancer Pain | Nausea With Vomiting Chemotherapy-Induced | Depression, ReactiveCanada